The government is doing the best possible for research on cancer and the Department of Biotechnology's funding for such activities has resulted in vastly improved understanding of the disease, Union Minister Harsh Vardhan said Friday.
Observing that cancer is a serious disease, the Science and Technology Minister told the Lok Sabha that best possible is being done for research on cancer.
All future health programmes would focus on preventive and promotive healthcare, Vardhan, who also helms the Ministry of Health and Family Welfare, said during the Question Hour.
Speaker Om Birla suggested that there can be a discussion in the House on cancer and Vardhan said that he would be happy to respond to queries.
The minister said the CSIR-National Institute of Science, Technology and Development Studies has not undertaken any research work to check damage to normal cells of the body during cancer treatment.
Apart from Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research, Department of Biotechnology, Department of Science & Technology, Ministry of AYUSH and Department of Atomic Energy are also working in the area of cancer.
Over the past decade, Department of Biotechnology's funding in cancer research has yielded a vastly improved understanding of the disease, including some of the genetic and environmental factors and biological mechanisms that cause or contribute to cancer, the minister said.
"The Department of Biotechnology has been supporting cancer research in an integrated way to develop new methods to prevent and treat the disease and conducts research especially in challenging areas pertaining to different types of cancer," Vardhan said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
